Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia

Published:2018-08-31 Issue:8 Volume:27 Page:1061-1068
ISSN:1899-5276
Container-title:Advances in Clinical and Experimental Medicine
language:
Short-container-title:Adv Clin Exp Med

Author:

Ben Mahmoud Lobna,Mdhaffar Moez,Frikha Rim,Ghozzi Hanen,Hakim Ahmed,Sahnoun Zouheir,Elloumi Moez,Zeghal Khaled

Publisher

Wroclaw Medical University

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous),Genetics (clinical),Internal Medicine,Pharmacology (medical),Reviews and References (medical)

Link

http://www.advances.umed.wroc.pl/pdf/2018/27/8/1061.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients;Cancer Chemotherapy and Pharmacology;2024-07-13

2. Involvement of the ABCB1 C3435T Variant but Not the MTHFR C677T or MTHFR A1298C Variant in High-Dose Methotrexate-Induced Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients in China;International Journal of General Medicine;2024-03

3. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma;Xenobiotica;2024-02-07

4. Genetic association study of rs1801133 of MTHFR, rs4646903 of CYP1A1, null mutation of GSTM1&GSTT1 with leukemia in the Jammu region of north Indian population;The Nucleus;2023-12-05

5. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia;European Journal of Pediatrics;2023-10-18